rolipram has been researched along with Pneumonia, Pneumococcal in 1 studies
Pneumonia, Pneumococcal: A febrile disease caused by STREPTOCOCCUS PNEUMONIAE.
Excerpt | Relevance | Reference |
---|---|---|
"Pneumococcal pneumonia is a leading cause of mortality worldwide." | 1.43 | Inhibition of Phosphodiesterase-4 during Pneumococcal Pneumonia Reduces Inflammation and Lung Injury in Mice. ( David, BA; Galvão, I; Garcia, CC; Queiroz-Junior, CM; Rachid, MA; Russo, RC; Silva, PM; Sousa, LP; Tavares, LP; Teixeira, MM; Vago, JP, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tavares, LP | 1 |
Garcia, CC | 1 |
Vago, JP | 1 |
Queiroz-Junior, CM | 1 |
Galvão, I | 1 |
David, BA | 1 |
Rachid, MA | 1 |
Silva, PM | 1 |
Russo, RC | 1 |
Teixeira, MM | 1 |
Sousa, LP | 1 |
1 other study available for rolipram and Pneumonia, Pneumococcal
Article | Year |
---|---|
Inhibition of Phosphodiesterase-4 during Pneumococcal Pneumonia Reduces Inflammation and Lung Injury in Mice.
Topics: Animals; Annexin A1; Anti-Bacterial Agents; Ceftriaxone; Cyclic Nucleotide Phosphodiesterases, Type | 2016 |